Davidsohn’s research interests include increasing longevity through age reversal and synthetic control of epigenetic modifications. Currently he is focusing on a project through George Church Research Group and the Wyss Institute’s Synthetic Biology platform to develop an age reversal therapeutic using CRSPR technology. Noah received his Bachelor’s degree at California Institute of Technology in 2006, Master’s degree from Princeton University in 2008, and Ph.D. degree from Massachusetts Institute of Technology in 2013. During his Ph.D., he worked in Ron Weiss’s Lab creating modular genetic circuits that could be predictably assembled from individual part characterization. Prior to joining the Wyss Institute in 2015, Noah was a postdoctoral fellow in the department of genetics at Harvard Medical School.